Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration [2]

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 10, 2002, Pages 872-873

  Jonas, Jost B ^a,b   Kreissig, Ingrid ^a,b   Degenring, Robert ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TRIAMCINOLONE ACETONIDE;

AGED; CASE REPORT; CATARACT; CATARACT EXTRACTION; CLINICAL OBSERVATION; DISEASE COURSE; DRUG TOLERABILITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; LETTER; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036938556     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0547-y     Document Type: Letter

References (5)

1. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA (1998) Exudative macular degeneration and intravitreal triamcinolone: 18-month follow-up. Aust N Z J Ophthalmol 26: 277-281
2. Danis RP, Ciulla TA, Pratt LM, Anliker W (2000) Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-250
3. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S (2001) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 131: 468-471
4. Machemer R (1988) Proliferate vitreoretinopathy (PVR). A personal account of its pathogenesis and treatment. Proctor lecture. Invest Ophthalmol Vis Sci 29: 1771-1783
5. Yang CS, Khawly JA, Hainsworth DP, Chen SN, Ashton P, Guo H, Jaffe GJ (1998) An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental vitreoretinopathy. Arch Ophthalmol 116: 69-77